Customized cancer cell weapons: Using CRISPR dCas9 genetic engineering to modify MCF7 human breast cancer cells into double agent treatment vectors
2016 ◽
Vol 13
(5)
◽
pp. 4303-4308
◽
Keyword(s):
2012 ◽
Vol 35
(1)
◽
pp. 98-104
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
2000 ◽
2001 ◽
2003 ◽